Delivery Order HHSN271201700014I-75N95020F00001
Award Date 9/16/20
Potential Completion Date 7/23/21
Potential Value $439K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Menlo Park, CA 94025, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, and was awarded to Sri International, a non-profit research institute. The contract, valued at $144,154.00, is for delivery order C-04, which provides chemistry and manufacturing services. The period of performance is from June 21, 2019 to June 20, 2020, with a completion date of December 14, 2023. The contract type is cost...
- This is a $4,866,923.00 delivery order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute, for preclinical services to support the development of therapeutics against antimicrobial resistant organisms. The delivery order is part of a larger program titled "Preclinical Services for the Development of Interventional Agents for Infectious Diseases." There is no set-aside designation...
- This is a Delivery Order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Sri International, a non-profit research institute, for Nonclinical Services for the Development of Interventional Agents for Infectious Diseases. The contract has a Firm Fixed Price type and a potential value of $157,734.00. It does not utilize any set-aside designation. The contract is under a larger Nonclinical Services for Development of...
- This is a $117,119.24 cost-plus-fixed-fee delivery order contract awarded to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the process development and synthesis of 100 grams of ARN0075039, a non-GMP material. It is part of the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The award has no...
- This is a cost-plus-fixed-fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Sri International, a non-profit research and development institute. The $25,378,188.00 contract is for safety evaluations of anti-infective therapies, with a period of performance ending on July 30, 2007. Sri International, which has expertise across various scientific and engineering...
- This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Sri International, a non-profit research institute. The $260,406.00 contract is for task order B-01 under the "Nonclinical Services for Development of Interventional Agents" indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The task order is for lead identification, development,...
- This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order...
- This is a cost-plus-fixed-fee contract awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute. The $1,439,619 contract supports pharmacology and toxicology studies of several experimental compounds, including amikacin, TLC-ART-101, NDB-compounds, and sutezolid. The goal is to develop mitochondrial toxicity assays to support the preclinical development of AIDS therapeutics under the NIAID's...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Sri International, a non-profit research institute. The $143,126.00 cost-plus-fixed-fee contract is for non-clinical services to support the development of interventional agents for infectious diseases. The work will be performed in West Menlo Park, California. The contract is a delivery order under a larger indefinite delivery...
- This is a federal contract award to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS). The contract, a Delivery Order with a cost plus fixed fee pricing type, is for pre-clinical services to support the development of interventional agents for infectious diseases. The contract has a ceiling value of $5,491,527.88 and a period of...